Skip to main content

GOLDMAN SACHS GROUP INC

Position in QNCX — Quince Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in QNCX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,622
-$767,856 QoQ
Shares Held
80
-93.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in QNCX Over Time

Shares Held

Position Value (USD)

Derivatives in QNCX

reported options exposure · as of Sep 30, 2021
CallValue
$458,300
CallShares
25
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in QNCX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,622 16,064
2025-12-31 $769,478 229,695
2022-09-30 $39,365 29,598
2022-06-30 $196,145 88,354
2022-03-31 $381,309 61,601
2021-12-31 $1,555,818 123,282
2021-09-30 $3,743,486 40,841
2021-09-30 $458,300 5,000
2021-06-30 $265,000 5,000
2021-06-30 $1,301,468 24,556
2021-03-31 $745,063 20,679
2020-12-31 $1,347,023 48,489
2020-09-30 $1,904,400 38,088
2020-06-30 $1,790,235 38,666